Patent ID: 7736853
Filing Date: 2010-06-15
Classification: C07K,C12Q,G01N

Abstract:
1. A method of detecting an androgen-independent prostate cancer cell in a sample comprising prostate cells from a patient having undergone androgen ablation therapy, the method comprising: obtaining the sample comprising prostate cells from the patient having undergone androgen ablation therapy; determining in the sample the presence or absence of two or more nucleic acids selected from the group consisting of SEQ. ID NO. 24, SEQ. ID NO. 3, SEQ. ID NO. 5, SEQ. ID NO. 7, SEQ. ID NO. 9, SEQ. ID NO. 53, SEQ. ID NO. 29, SEQ. ID NO. 54, SEQ. ID NO. 55, SEQ. ID NO. 56, SEQ. ID NO. 57, and SEQ. ID NO. 58, and correlating the presence of a nucleic acid comprising the sequence of SEQ. ID NO. 24 to the presence of said androgen-independent prostate cancer cell, and the absence of a nucleic acid comprising the sequence of SEQ. ID NO. 3, SEQ. ID NO. 5, SEQ. ID NO. 7, SEQ. ID NO. 9, SEQ. ID NO. 53, SEQ. ID NO. 29, SEQ. ID NO. 54, SEQ. ID NO. 55, SEQ. ID NO. 56, SEQ. ID NO. 57, or SEQ. ID NO. 58 to the presence of said androgen-independent prostate cancer cell.